Grant Aids Sami Labs to Test Plant Species and Evaluate Commercial Viability in a Sustainable Manner
The Department of Scientific and Industrial Research (DSIR), under the Government of India’s Ministry of Science and Technology has sanctioned funding to Sabinsa’s parent company Sami Labs for research on “Development and standardization of manufacturing processes for large scale production of valuable secondary metabolites from callus-derived cells of vascular cambial explants of selected woody plant species.”
The Sami-Sabinsa Group’s Nelamangala biotechnology site in Bengaluru, India has been audited by the United States Pharmacopeia (USP) and received a GMP compliance certificate on February 25, 2019.
- Press Release
Sabinsa announces that it has been awarded Japanese Patent Number 6472453, US Patent Number 10085963, and Australian Patent Number 2015351423, entitled “Process and compositions for achieving mammalian energy balance.”
East Windsor, NJ (March 29, 2019) –Sabinsa announces the introduction of LactoSporin®, an ingredient for cosmeceutical products that has antimicrobial, antioxidant, anti-inflammatory, and anti-collagenase properties, shows protective efficacy against UV radiation, environmental pollutants, and prevents microbial biofilm formation, induces hair growth, and prevents accelerated skin aging.
- Press Release
The Sami-Sabinsa Group’s ambitious 10-year reforestation program of Pterocarpus Marsupium trees in India has been chosen as one of two finalists in the NutraIngredients-USA Editors Award for Industry Initiative of the Year. The winner will be announced at an event in Chicago on July 16, 2018.